Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/221528
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorRuiz de Porras, Vicenç-
dc.contributor.authorSánchez-Ocaña Paz, Marina-
dc.date.accessioned2025-06-13T11:24:06Z-
dc.date.available2025-06-13T11:24:06Z-
dc.date.issued2025-04-
dc.identifier.urihttps://hdl.handle.net/2445/221528-
dc.descriptionTreballs Finals de Grau de Farmàcia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 2025. Tutor: Vicenç Ruiz de Porras Fondevilaca
dc.description.abstractBisphenols, PCBs, Parabens, and Dioxins: The Silent Threat of Endocrine Disruptors in Breast Cancer This study investigates the potential role of endocrine disrupting chemicals (EDCs) in breast cancer development and progression. The primary objective is to analyse how bisphenols, polychlorinated biphenyls (PCBs), parabens, and dioxins contribute to oncogenic processes by disrupting hormonal balance, altering gene expression, and modifying the tumour microenvironment. Specifically, this review aims to identify key exposure pathways, elucidate molecular mechanisms of action, and evaluate their public health implications. To achieve this, a comprehensive literature review was conducted using peer-reviewed scientific databases, focusing on studies published from 2019 onward. The findings reveal that BPA promotes cell proliferation, migration, epigenetic alterations, and immune suppression, accelerating tumour progression. PCBs influence gene expression and cellular metabolism, but their correlation with breast cancer remains inconclusive. Parabens exhibit estrogenic activity, increasing oxidative stress and tumour growth, while dioxins contribute to metastasis, inflammation, and therapy resistance. Epidemiological studies suggest that high exposure levels-mainly through diet, environmental contamination, and personal care products-are associated with increased breast cancer risk. In conclusion, EDCs play a significant role in breast cancer, although further research is needed to address existing knowledge gaps. Moreover, stronger regulatory preventive measures should be reinforced to minimize exposure and mitigate associated health risks. Moreover, raising public awareness and promoting the development of safer alternatives are crucial steps in reducing the impact of these chemicals on human health. Key words: Endocrine disrupting chemicals, breast cancer, bisphenols, polychlorinated biphenyls, parabens, dioxinsca
dc.format.extent43 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoengca
dc.rightscc-by-nc-nd (c) Marina Sánchez-Ocaña Paz, 2025-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceTreballs Finals de Grau (TFG) - Farmàcia-
dc.subject.classificationDisruptors endocrinscat
dc.subject.classificationCàncer de mamacat
dc.subject.classificationFenolscat
dc.subject.classificationTreballs de fi de graucat
dc.subject.otherEndocrine disrupting chemicalseng
dc.subject.otherBreast cancereng
dc.subject.otherPhenolseng
dc.subject.otherBachelor's theseseng
dc.titleBisphenols, PCBs, Parabens, and Dioxins: The Silent Threat of Endocrine Disruptors in Breast Cancerca
dc.typeinfo:eu-repo/semantics/bachelorThesisca
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca
Appears in Collections:Treballs Finals de Grau (TFG) - Farmàcia

Files in This Item:
File Description SizeFormat 
TFG_Sanchez_Ocaña_Marina.pdf1.44 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons